Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) is one of the best drug stocks to buy according to analysts. On April 17, UBS ...

The four-member group, set to reunite for the first time in years, will make stops at L.A.’s Crypto.com Arena and New York’s ...

UBS expects strong earnings from Apple Inc. (NASDAQ:AAPL) as the company continues to roll out personal devices that remain ...

Shares of Seagate Technology (NASDAQ:STX | STX Price Prediction) and Western Digital (NASDAQ:WDC) capped a blockbuster April ...

Nucor Corporation (NYSE:NUE) was among the stocks on Jim Cramer’s Mad Money radar as he discussed the recent sell-off in ...

Government bond yields have crept higher, presenting a compelling entry point for investors, according to the bank.

Apple (AAPL) reports Q2 FY26 earnings today. Analysts expect $109B revenue and $1.95 EPS. Key focus: iPhone sales in China ...

Raymond James is also welcoming a $400M Merrill Lynch duo in Lexington, Kentucky, while RBC adds a $542 million UBS team in ...

Ford (F) stock fell despite crushing Q1 earnings with $3.5B operating profit vs $1.3B expected. UBS cuts price target. Here's ...

Michael Yee, UBS global head of biotech research, joins 'Squawk Box' to discuss the quarterly earnings results of Merck and Eli Lilly, opportunities in pharma stocks, and more.

Still, questions remain around Stellantis's performance in the important North American market. U.S. sales rose 4% on year over the quarter, and the adjusted operating margin for the wider region was ...

Q1 2026 earnings call: cycle-trough signals, resilient aftermarket profits, growth acquisition, and emissions-rule risks—read ...